F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma
Clinical trial NCT02054884 · TERMINATED
Trial details
- NCT number
- NCT02054884
- Sponsor
- Philogen S.p.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-25
- Primary completion
- 2016-12-31
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.